Retrospective review of drug‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution

Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept

(2019) Jérôme Coulombe et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis

(2019) Christopher H. Pham et al.   BURNS

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

(2018) Chuang-Wei Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept

(2018) Geneviève M. Gavigan et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Clinical Features of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2018) Satoshi Sato et al.   PEDIATRICS INTERNATIONAL

A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis

(2018) James W. Antoon et al.   Journal of Allergy and Clinical Immunology-In Practice

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States

(2018) Robert G. Micheletti et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Amniotic membrane transplants in the pediatric population

(2017) Mariam S. Ahmad et al.   JOURNAL OF AAPOS

Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States

(2017) Derek Y. Hsu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal Necrolysis

(2017) Jennifer Sorrell et al.   PEDIATRIC DERMATOLOGY

Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2017) Stefanie Zimmermann et al.   JAMA Dermatology

Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis

(2016) R.P. Dodiuk-Gad et al.   BRITISH JOURNAL OF DERMATOLOGY

Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis – A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease

(2016) Sahar Kohanim et al.   Ocular Surface

Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital

(2016) Leelawadee Techasatian et al.   World Journal of Pediatrics

Corticosteroids in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

(2014) Ernest H. Law et al.   ANNALS OF PHARMACOTHERAPY

Mycoplasma pneumoniae-Associated Mucocutaneous Disease in Children: Dilemmas in Classification

(2014) Brea Prindaville et al.   PEDIATRIC DERMATOLOGY

Pediatric Toxic Epidermal Necrolysis

(2013) Gavin M. Hamilton et al.   Journal of Burn Care & Research

The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis

(2012) Y.-C. Huang et al.   BRITISH JOURNAL OF DERMATOLOGY

Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a University Hospital

(2010) C. Ferrándiz-Pulido et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children

(2009) Mark Jean-Aan Koh et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Medications as Risk Factors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Pooled Analysis

(2009) N. Levi et al.   PEDIATRICS